Related Experiment Videos
Breast cancer: challenges and opportunities
1Indiana University School of Medicine, Indianapolis, USA.
Seminars in Oncology
|July 13, 2000
Summary
Breast cancer research is accelerating, but traditional drug development faces limitations. Biologically targeted therapies represent the most promising strategy for overcoming this disease.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Breast cancer research has accelerated due to increased awareness and technological advancements.
- The proliferation of new therapeutic agents presents significant practical and conceptual challenges for researchers.
- Current 'business-as-usual' drug development models are proving inadequate for the evolving research landscape.
Purpose of the Study:
- To evaluate the limitations of conventional drug development in the context of current breast cancer research.
- To propose alternative strategies for future drug development in breast cancer.
Main Methods:
- This report is a conceptual analysis and literature review.
- It examines the challenges posed by numerous new agents in breast cancer research.
- It critiques the "business-as-usual" approach to drug development.
Main Results:
- The traditional drug development paradigm exhibits significant limitations in addressing the complexities of modern breast cancer research.
- The current approach is insufficient to meet the demands of an increasingly crowded therapeutic field.
Conclusions:
- Future advancements in breast cancer treatment hinge on the development of biologically targeted therapies.
- These targeted approaches offer the most viable path toward defeating breast cancer.